Jaffe–Campanacci syndrome
Jaffe–Campanacci syndrome is a rare genetic disorder characterized by multiple non-ossifying fibromas, café-au-lait spots, and other skeletal abnormalities. It is named after the American pathologist Henry L. Jaffe and the Italian pathologist Mario Campanacci, who first described the syndrome.
Clinical Features[edit | edit source]
Individuals with Jaffe–Campanacci syndrome typically present with:
- Non-ossifying fibromas: These are benign bone lesions that are commonly found in the long bones such as the femur and tibia.
- Café-au-lait spots: These are light brown skin patches that are often present at birth or develop in early childhood.
- Skeletal abnormalities: These may include scoliosis, kyphosis, and other bone deformities.
- Ocular abnormalities: Some patients may have congenital cataracts or other eye issues.
- Cardiovascular anomalies: Rarely, individuals may have heart defects.
Diagnosis[edit | edit source]
The diagnosis of Jaffe–Campanacci syndrome is primarily clinical, based on the presence of characteristic features. Imaging studies such as X-rays and MRI can help in identifying non-ossifying fibromas and other skeletal abnormalities. Genetic testing may be used to confirm the diagnosis and to differentiate it from other similar conditions.
Differential Diagnosis[edit | edit source]
Jaffe–Campanacci syndrome should be differentiated from other conditions that present with similar features, such as:
Management[edit | edit source]
There is no cure for Jaffe–Campanacci syndrome, and treatment is primarily supportive. Management may include:
- Regular monitoring of bone lesions and skeletal abnormalities.
- Surgical intervention for significant bone deformities or fractures.
- Ophthalmologic evaluation and management of eye issues.
- Cardiovascular assessment if heart defects are present.
Prognosis[edit | edit source]
The prognosis for individuals with Jaffe–Campanacci syndrome varies depending on the severity of the skeletal and other associated abnormalities. With appropriate management, many individuals can lead relatively normal lives.
See Also[edit | edit source]
- Non-ossifying fibroma
- Café-au-lait spot
- Scoliosis
- Neurofibromatosis type I
- McCune-Albright syndrome
- Fibrous dysplasia
References[edit | edit source]
External Links[edit | edit source]
-
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD